| Literature DB >> 27447650 |
War War May Zin1,2, Suradet Buttachon3,4, Tida Dethoup5, Carla Fernandes6,7, Sara Cravo8,9, Madalena M M Pinto10,11, Luís Gales12,13, José A Pereira14, Artur M S Silva15, Nazim Sekeroglu16, Anake Kijjoa17,18.
Abstract
Two new cyclotetrapeptides, sartoryglabramides A (5) and B (6), and a new analog of fellutanine A (8) were isolated, together with six known compounds including ergosta-4, 6, 8 (14), 22-tetraen-3-one, ergosterol 5, 8-endoperoxide, helvolic acid, aszonalenin (1), (3R)-3-(1H-indol-3-ylmethyl)-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione (2), takakiamide (3), (11aR)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione (4), and fellutanine A (7), from the ethyl acetate extract of the culture of the marine sponge-associated fungus Neosartorya glabra KUFA 0702. The structures of the new compounds were established based on extensive 1D and 2D spectral analysis. X-ray analysis was also used to confirm the relative configuration of the amino acid constituents of sartoryglabramide A (5), and the absolute stereochemistry of the amino acid constituents of sartoryglabramide A (5) and sartoryglabramides B (6) was determined by chiral HPLC analysis of their hydrolysates by co-injection with the d- and l- amino acids standards. Compounds 1-8 were tested for their antibacterial activity against Gram-positive (Escherichia coli ATCC 25922) and Gram-negative (Staphyllococus aureus ATCC 25923) bacteria, as well as for their antifungal activity against filamentous (Aspergillus fumigatus ATCC 46645), dermatophyte (Trichophyton rubrum ATCC FF5) and yeast (Candida albicans ATCC 10231). None of the tested compounds exhibited either antibacterial (MIC > 256 μg/mL) or antifungal activities (MIC > 512 μg/mL).Entities:
Keywords: Mycale sp.; Neosartorya glabra; cyclotetrapeptides; diketopiperazines; fellutanine A epoxide; marine-derived fungus; sartoryglabramides A and B
Mesh:
Substances:
Year: 2016 PMID: 27447650 PMCID: PMC4962026 DOI: 10.3390/md14070136
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Secondary metabolites isolated from the ethyl acetate extract of the culture of N. glabra KUFA 0702.
1H and 13C NMR (DMSO, 500 MHz and 125 MHz) and HMBC assignment for 5.
| Position | δC, Type | δH, ( | COSY | HMBC | |
|---|---|---|---|---|---|
| Anthranilic acid | 1 | 166.5, C | - | ||
| 2 | 124.8, C | - | |||
| 3 | 126.6, CH | 7.55, dd (7.7, 1.3) | H-4 | C-1, 5, 7 | |
| 4 | 122.4, CH | 7.16, dd (7.9, 7.7) | H-3, 5 | C-2, 6 | |
| 5 | 130.4, CH | 7.48, ddd (7.9, 7.9, 1.4) | H-4, 6 | C-3, 7 | |
| 6 | 120.4, CH | 8.31, dd (7.9, 0.5) | H-5 | C-2, 4 | |
| 7 | 136.5, C | - | |||
| NH-8 | - | 9.40, s | - | C-2, 6, 9 | |
| Phe-I | 9 | 168.8, CO | - | ||
| 10 | 55.2, CH | 4.36, ddd (8.4, 7.8, 5.3) | H-11, NH-21 | C-9, 11, 12 | |
| 11a | 34.7, CH2 | 2.97, dd (13.9, 8.4) | H-10, 11b | C-9, 10, 12, 13, 17 | |
| b | 3.23, dd (13.9, 5.3) | H-10, 11a | C-9, 10, 12, 13, 17 | ||
| 12 | 138.3, C | - | |||
| 13 | 129.6, CH | 7.08, dd (7.4, 1.4) | H-14 | C-11, 15, 17 | |
| 14 | 128.0, CH | 7.19, dd (7.4, 7.4) | H-14, 15 | C-12, 16 | |
| 15 | 126.0, CH | 7.18, dd (7.4, 7.4) | H-14, 16 | C-13, 17 | |
| 16 | 128.0, CH | 7.19, dd (7.4, 7.4) | H-15, 17 | C-12, 14 | |
| 17 | 129.6, CH | 7.08, dd (7.4, 1.4) | H-16 | C-11, 13, 15 | |
| NH-18 | - | 8.49, d (7.8) | H-20 | C-10, 19 | |
| Phe-II | 19 | 169.9, CO | - | ||
| 20 | 54.4, CH | 4.58, ddd (9.8, 8.9, 7.3) | H-21a, b | C-19, 21, 22 | |
| 21a | 37.1, CH2 | 2.71, dd (13.5, 8.9) | H-21b, 20 | C-19, 20, 22, 23, 27 | |
| b | 2.94, dd (13.5, 7.3) | H-21a, 20 | C-19, 20, 22, 23, 27 | ||
| 22 | 137.3, C | - | |||
| 23 | 129.1, CH | 7.14, dd (7.4, 1.4) | H-24 | C-25, 27 | |
| 24 | 128.1, CH | 7.27, dd (7.4, 7.4) | H-23, 25 | C-22, 26 | |
| 25 | 126.3, CH | 7.23, dd (7.4, 7.4) | H-24, 26 | C-23, 27 | |
| 26 | 128.1, CH | 7.27, dd (7.4, 7.4) | H-25, 27 | C-22, 24 | |
| 27 | 129.1, CH | 7.14, dd (7.4, 1.4) | H-26 | C-23, 25 | |
| NH-28 | - | 7.41, d (9.8) | H-20 | C-19, 20, 29 | |
| Pro | 29 | 170.2, CO | - | ||
| 30 | 62.2, CH | 4.20, dd (9.8, 2.3) | H-31a, b | C-29, 31, 32 | |
| 31a | 28.3, CH2 | 1.54, m | H-30, 31b |
| |
| b | 2.12, m | H-30, 31a | C-29, 30 | ||
| 32 | 24.6, CH2 | 1.89, m | H-31a, b, 32a, b | ||
| 33a | 49.4, CH2 | 3.70, dd (17.6, 9.6) | H-32, 33b | C-30, 32 | |
| b | 3.63, m | H-32, 33a | |||
| N-34 | - | - |
Figure 2Key COSY (—) and HMBC (→) correlations of compound 5.
Figure 3Ortep view of compound 5.
1H and 13C NMR (DMSO, 500 MHz and 125 MHz) and HMBC assignment for 6.
| Position | δC, Type | δH, ( | COSY | HMBC | |
|---|---|---|---|---|---|
| Anthranilic acid | 1 | 166.4, CO | - | ||
| 2 | 125.2, C | - | |||
| 3 | 126.5, CH | 7.53, d (7.6) | H-4 | C-1, 5, 7 | |
| 4 | 122.6, CH | 7.16, dd (7.6, 7.6) | H-3, 5 | C-2, 6 | |
| 5 | 130.4, CH | 7.48, ddd (8.3, 7.6) | H-4, 6 | C-3, 7 | |
| 6 | 120.7, CH | 8.27, d (8.3) | H-5 | C-2, 4 | |
| 7 | 136.3, C | - | |||
| NH-8 | - | 9.25, s | C-2, 6, 9 | ||
| Trp | 9 | 169.0, CO | - | ||
| 10 | 54.3, CH | 4.52, ddd (7.9, 6.7, 5.9) | H-11, NH-21 | C-9, 11, 12, 22 | |
| 11a | 24.9, CH2 | 3.32, dd (14.7, 5.9) | H-10, 11b | C-9, 10, 12, 13, 20 | |
| b | 3.14, dd (14.7, 6.7) | H-10, 11a | C-9, 10, 12, 13, 20 | ||
| 12 | 110.2, C | - | |||
| 13 | 127.7, C | - | |||
| 14 | 118.5, CH | 7.58, d (7.9) | H-15 | C-16, 18 | |
| 15 | 118.2, CH | 6.98, dd (7.9, 7.5) | H-14, 16 | C-13, 17 | |
| 16 | 120.8, CH | 7.06, dd (8.0, 7.5) | H-15, 17 | C-14, 18 | |
| 17 | 111.3, CH | 7.34, d (8.0) | H-16 | C-13, 15 | |
| 18 | 136.0, C | - | |||
| NH-19 | - | 10.82, brs | H-20 | C-12, 13, 18, 20 | |
| 20 | 124.0, CH | 7.04, d (1.8) | NH-19 | C-13 | |
| NH-21 | - | 8.42, d (7.9) | H-10 | C-9, 22 | |
| Phe | 22 | 170.1, CO | - | ||
| 23 | 54.6, CH | 4.61, ddd (10.0, 10.0, 6.4) | H-24a, b | C-24, 32 | |
| 24a | 37.0, CH2 | 2.66, dd (13.6, 10.0) | H-23, 24b | C-22, 23, 25, 26, 30 | |
| b | 2.92, dd (13.6, 6.4) | H-23, 24a | C-22, 23, 25, 26, 30 | ||
| 25 | 134.4, C | - | |||
| 26 | 129.0, CH | 7.10, dd (7.7, 1.0) | H-27 | C-25 | |
| 27 | 128.1, CH | 7.20, m | H-26, 28 | C-25 | |
| 28 | 126.3, CH | 7.18, m | H-27, 29 | ||
| 29 | 128.1, CH | 7.20, m | H-28, 30 | C-28 | |
| 30 | 129.0, CH | 7.10, dd (7.7, 1.0) | H-29 | C-25 | |
| NH-31 | - | 7.38, d (10.0) | H-23 | C-32 | |
| Pro | 32 | 170.2, CO | - | ||
| 33 | 62.1, CH | 4.15, dd (9.0, 1.2) | H-34a, b | C-32 | |
| 34a | 28.3, CH2 | 1.45, m | H-33, 34b | ||
| b | 2.09, m | H-33, 34a | |||
| 35 | 24.6, CH2 | 1.86, m | H-34a,b, 36a, b | ||
| 36a | 49.4, CH2 | 3.55, m | H-35, 36b | ||
| b | 3.67, m | H-35, 36a | |||
| N-37 | - | - |
Figure 4Key COSY (—) and HMBC (→) correlations of compound 6.
1H and 13C NMR (DMSO, 300 and 75 MHz), HMBC assignment and NOESY for 8.
| Position | δC, type | δH, ( | COSY | HMBC | NOESY |
|---|---|---|---|---|---|
| 2 | 124.1, CH | 7.25, d (2.3) | NH-1 | C-3, 9 | H-10a, 11 (str), NH-13′ |
| 3 | 109.5, C | - | |||
| 4 | 118.5, CH | 7.60, d (7.9) | H-5 | C-3, 6, 8 | H-10a, 11 (str) |
| 5 | 118.3, CH | 6.99, ddd (7.9, 7.9, 0.5) | H-4, 6 | C-7, 9 | |
| 6 | 120.9, CH | 7.07, ddd (7.9, 7.9, 1.1) | H-5, 7 | C-4, 8 | |
| 7 | 111.3, CH | 7.33, d (7.9) | H-6 | C-5, 9 | |
| 8 | 136.0, C | - | |||
| 9 | 127.4, C | - | |||
| 10a | 24.7, CH2 | 3.06, dd (15.7, 6.5) | H-10b, 11 | C-3, 9, 11, 12 | H-4, 10b, 11, NH-13′ |
| b | 3.40, m | H-10a, 11 | C-3, 9, 11, 12 | H-10a | |
| 11 | 55.1, CH | 4.46, t (5.1) | H-10a, 10b | C-3, 10, 12 | H-2, 4, 10a, 11′, NH-13′ |
| 12 | 167.7, CO | - | |||
| 2′ | 84.0, CH | 5.33, d (4.1) | NH-1′ | C-3′, 10′ | H-11, NH-13, NH-1′ (str) |
| 3′ | 85.9, C | - | |||
| 4′ | 122.5, CH | 7.18, d (7.4) | H-5′ | C-6′, 8′ | NH-13 |
| 5′ | 117.8, CH | 6.61, ddd (7.8, 7.4, 0.5) | H-4′, 6′ | C-7′, 9′ | |
| 6′ | 128.9, CH | 7.05, ddd (7.8, 7.8, 1.3) | H-5′, 7′ | C-4′, 8′ | |
| 7′ | 109.8, CH | 6.54, d (7.8) | H-6′ | C-5′, 9′ | |
| 8′ | 148.4, C | - | |||
| 9′ | 131.1, C | - | |||
| 10′a | 41.3, CH2 | 1.83, dd (13.0, 11.6) | H-10′b, 11 | C-11′, 12′ | H-10′b |
| b | 2.43, dd (13.6, 6.7) | H-10′a, 11 | C-3′ | H-10′a, 11′ | |
| 11′ | 58.6, CH | 4.66, dd (11.6, 6.7) | H-10′a, 10b | C-10′, 12′ | H-11, 2′, 10′b |
| 12′ | 169.8, CO | - | |||
| NH-1 | - | 10.88, brd (1.4) | H-2 | C-2, 3, 8, 9 | H-2, 4 |
| NH-1′ | - | 6.68, d (4.1) | H-2′ | C-3′, 9′ | |
| NH-13 | - | 6.05, s | - | C-10′ | H-2′, 4′ |
| NH-13′ | - | 7.72, brs | - | C-10, 11, 11′, 12 | H-10a (str), 11 (str), H-2 |
Figure 5Key COSY (—) and HMBC (→) correlations of compound 8.
Figure 6Key NOESY (↔) correlations of compound 8.
Figure 7The two possible epoxide configurations for 8 in their lowest RHF/6-21G total energy conformation. Solid lines indicate direct NOESY correlations, explained by the S/S stereoisomer and not by the R/R. The discontinuous line shows how spin diffusion gives rise to an H-2′/NH-13 NOESY cross-peak.